FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

41190311000001109: Primidone 250mg tablets (Aspire Pharma Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 23-Nov 2022. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
2509881000001111 Primidone 250mg tablets (Aspire Pharma Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
2509891000001113 Primidone 250mg tablets (Aspire Pharma Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Primidone 250mg tablets (Aspire Pharma Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Primidone 250mg tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Primidone 250mg tablets (Aspire Pharma Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Primidone 250mg tablets (Aspire Pharma Ltd) Is a Product containing precisely primidone 250 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Primidone 250mg tablets (Aspire Pharma Ltd) VMP prescribing status (attribute) Caution - AMP level prescribing advised true Inferred relationship Existential restriction modifier
Primidone 250mg tablets (Aspire Pharma Ltd) Has specific active ingredient Primidone true Inferred relationship Existential restriction modifier
Primidone 250mg tablets (Aspire Pharma Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Primidone 250mg tablets (Aspire Pharma Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Primidone 250mg tablets (Aspire Pharma Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Primidone 250mg tablets (Aspire Pharma Ltd) 100 tablet 10 x 10 tablets Has AMP True Primidone 250mg tablets (Aspire Pharma Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start